MAPT and Alzheimer disease: Interestingly, in a Down syndrome mouse model (with Down Syndrome being one of the highest risks for developing AD), NSC transplantation into the hippocampus did actually reduce Tau extracellular granules [321], possible equivalents to the NFTs which are early markers of AD.